plex genomic rearrangements) within a particular chromosomal segment. They usually are 1 kb in length or larger. 5 Since the discovery of the important role of CNVs in human genome variability and also the recent development of high-resolution microarraybased technologies, a number of studies using these variants as genetic markers have emerged. Hence, CNVs are considered high risk factors for a considerable fraction of inherited and acquired diseases. [5] [6] [7] In Asian Journal of Andrology, a recent report by Zhang et al. 8 provided some evidence for the potential involvement of CNVs in Kallmann syndrome. The authors used the array technology to investigate the genomewide profile of structural variations in one consanguineous family with Kallmann syndrome. 8 The results revealed that affected individuals had common CNVs (microdeletions) on five distinct chromosomal regions: 1p21.1, 2q32.2, 8q21.13, 14q21.2 and Xp22.31. Interestingly, the variant on Xp22.31 was found in an intronic region of KAL1, a gene responsible for X-linked form of Kallmann syndrome. Molecular testing for KAL1 (and also for FGFR1) was found to be normal, 8 although alterations outside the exonic and splice site junction regions typically studied could not be excluded. In addition, genomic microdeletion in this Xp22.3 CNV was found in one of 29 Han Chinese sporadic Kallmann syndrome patients and in one of four other familial cases, but not in 26 Han Chinese sporadic normosmic IHH. 8 Although the work of Zhang et al. 8 was based in a very limited number of family members, the rare variants found only among the affected individuals account for a step further towards the better understanding of hypogonadotropic hypogonadism pathophysiology. For example, do the CNVs in the intronic region of KAL1 have any impact on these gene activities? Because CNVs are increasingly implicated in numerous diseases through a variety of mechanisms, 5 it is possible that an intronic microdeletion disrupts control elements of splicing, leading to gene loss-of-function. Even though the intronic CNV in KAL1 gene variant was not found neither in healthy family members nor in a control population suggesting that possibly it is phenotypically unfavorable, the pathological relevance of this variant will merit further investigations.
The paper also highlights the importance of CNVs in genome-wide projects to eventually help researchers to locate promising candidate genes for complex diseases. For instance, systematic exploration of CNVs in association studies have found susceptibility to HIV-1, lupus and Crohn's disease involving CNVs in CCL3L1, FCGR3B and C4, and DEFB4 genes, respectively (reviewed in Refs 5 and 7). Zhang et al. 8 have also identified four autosomal CNVs that could be associated with Kallmann syndrome. However, we cannot exclude that these results represent false-positive findings; thus, replication is needed before one can conclude that these genomic regions contain genes that modulate human IHH. Accordingly, extensive genomic scanning for variations in new series of Kallmann syndrome and normosmic IHH could provide additional support for the results of Zhang et al. 8 or underline other interesting regions related to IHH. It is undeniable that information provided by such studies is critical to improve our knowledge in the molecular basis of IHH and should be encouraged in years to come. The major challenge will be accurate interpretation of how genomic imbalances could be pathogenic in this disease.
